UK received $8.8 million from NIDA as part of the Justice Community Opioid Innovation Network (JCOIN) to support research on addiction treatment for opioid use disorder in criminal justice settings nationwide.
The University of Kentucky College of Pharmacy will host its tenth annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m. – 5:30 p.m. on Tuesday, Nov. 12, 2019, in room 124 of the Lee T. Todd, Jr. Building.
Dr. Michelle Lofwall, UK College of Medicine, is one of three national addiction physician experts who led a team of healthcare professionals in developing a new core curriculum designed to educate primary care providers on the prevention, assessment and treatment of substance use disorders (SUD) throughout the continuum of care.
Few regions have been hit harder by the drug epidemic than Kentucky and need increased access to evidence-based treatment for substance use disorders. The University of Kentucky Department of Psychiatry saw that need and developed a new clinic to better support patients.
Faculty from the Dept of Psychology in the College of Arts & Sciences and Behavioral Science in the College of Medicine have received two, five-year Research Project Grants from the NIH to study neurobehavioral processes involved in drug use disorders.
As a busy trauma surgeon, Dr. Phillip Chang saw his fair share of patients who were dealing with significant pain. As per the standards then, these patients would receive opioids for pain management. Most recovered and were weaned off the medication as planned.